| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.21B | — |
| Operating expense | — | — |
| Net income | 192.80M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, J7Z.F returned +108.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +56.4% |
| 1 year | +108.2% |
| 5 years | +101.7% |
| 10 years | +100.6% |
| All-time high | €223.40 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in J7Z.F would be worth today ›No. Jazz Pharmaceuticals plc has not paid a dividend in the past 12 months.
Jazz Pharmaceuticals plc is part of the Healthcare sector.
Jazz Pharmaceuticals plc has a market cap of 14.50B EUR, based on the latest quote.
